Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00373997 · ClinicalTrials.gov registry record · Phase 4
Esophageal and Laryngeal Tissue Changes in Patients Suspected of Having Laryngopharyngeal Reflux
A Phase 4 study of Gastroesophageal Reflux and Larynx Disease, sponsored by Vanderbilt University.
- Completed
- Registry status
- Phase 4
- Development phase
- 45
- Enrollment target
- 1
- Study location
NCT00373997 is a Phase 4 study of Gastroesophageal Reflux and Larynx Disease that has completed, run by Vanderbilt University. The registered enrollment target is 45 participants, below the 183-participant average among 25 other Gastroesophageal Reflux trials with a reported enrollment target (75% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00373997, a Phase 4 study of Gastroesophageal Reflux and Larynx Disease, has completed, sponsored by Vanderbilt University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 45 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the study is to determine whether patients with suspected Laryngopharyngeal reflux have inflammation and ultrastructural injury on their laryngeal biopsies.
Conditions Studied
Interventions
- PROCEDURE Esophageal and Laryngeal biopsies
- PROCEDURE egd with biopsy
Study Locations (1)
Tennessee
- Vanderbilt University Medical Center, Endoscopy Lab, TVC 1410 - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2006-09 |
| Est. Completion | 2009-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00373997
The ClinicalTrials.gov registry entry for NCT00373997 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 183-participant average among 25 other Gastroesophageal Reflux trials with a reported enrollment target (75% lower). The listed sponsor is Vanderbilt University, which has 430 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Gastroesophageal Reflux appearing as the primary indexed condition, and to 2 interventions - of which Esophageal and Laryngeal biopsies is the first listed.
NCT00373997 reports 1 study location spanning 1 distinct geographic area - top geographies include Tennessee.
Frequently Asked Questions
What is clinical trial NCT00373997 about?
NCT00373997 is a clinical study titled "Esophageal and Laryngeal Tissue Changes in Patients Suspected of Having Laryngopharyngeal Reflux". The purpose of the study is to determine whether patients with suspected Laryngopharyngeal reflux have inflammation and ultrastructural injury on their laryngeal biopsies.
What is the current status of trial NCT00373997?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 45 participants. The study started on 2006-09. Estimated completion is 2009-12.
What conditions does trial NCT00373997 study?
This clinical trial studies the following conditions: Gastroesophageal Reflux, Larynx Disease.
What interventions are being tested in trial NCT00373997?
The interventions under investigation include: Esophageal and Laryngeal biopsies (PROCEDURE), egd with biopsy (PROCEDURE).
Who is sponsoring clinical trial NCT00373997?
This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00373997 being conducted?
This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Gastroesophageal Reflux
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study of Breath Testing for Small Intestinal Bacterial Overgrowth
RECRUITING · NA
-
Transpyloric Versus Gastric Feeding in Bronchopulmonary Dysplasia
RECRUITING · NA
-
Compassionate Use of Domperidone for Refractory Gastroparesis
RECRUITING · NA
-
Barrett's Esophagus Related Neoplasia (BERN) Project
RECRUITING
-
External UES Band (Shaker Pressure Band) and GERD
RECRUITING · NA
-
Multi-Site Detection of Barrett's Esophagus in Patients Without Chronic GERD Symptoms
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.